Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Hyun MK, Yim JJ, Lee CH, Jang EJ, Lee NR, Kim K. [Utilization patterns and comparative effectiveness of inhaled bronchodilators/corticosteroids for patients with chronic airway diseases] Seoul: National Evidence-based Healthcare Collaborating Agency (NECA). NECA-C-11-004. 2012 Authors' conclusions The use of ICS is associated with a reduced risk of lung cancer but not of laryngeal cancer.
The use of ICS with LABA decreases the risk of hospital admission or ER visit for pneumonia, whereas the use of ICS alone may increase that risk.
ICS use increases the risk of TB in an intermediate-TB-burden country. Clinicians should be aware of the possibility of TB development among patients who are long-term high-dose ICS users. Indexing Status Subject indexing assigned by CRD MeSH Administration, Inhalation; Adrenal Cortex Hormoness; Bronchodilator Agents; Lung Diseases, Obstructive Country of organisation South Korea English summary An English language summary is available. Address for correspondence National Evidence-based Healthcare Collaborating Agency (NECA), Changkyung B/D 9F, Wonnam-dong 28-7, Jongno-gu, Seoul, South Korea
Email: hta_neca@neca.re.kr AccessionNumber 32013000664 Date abstract record published 18/09/2013 |